Author:
Salama Joseph K.,Schild Steven E.
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K., Felip, E., et al. (2012). Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23(Suppl 7), vii56–vii64. doi: 10.1093/annonc/mds226 .
2. Scagliotti, G. V., Parikh, P., von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., et al. (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. Journal of Clinical Oncology, 26(21), 3543–3551. doi: 10.1200/JCO.2007.15.0375 .
3. Lima, A. B., Macedo, L. T., & Sasse, A. D. (2011). Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis. PLoS One, 6(8), e22681. doi: 10.1371/journal.pone.0022681 .
4. Soria, J. C., Mauguen, A., Reck, M., Sandler, A. B., Saijo, N., Johnson, D. H., et al. (2013). Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer. Annals of Oncology, 24(1), 20–30. doi: 10.1093/annonc/mds590 .
5. Mok, T. S., Wu, Y. L., Thongprasert, S., Yang, C. H., Chu, D. T., Saijo, N., et al. (2009). Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. New England Journal of Medicine, 361(10), 947–957. doi: 10.1056/NEJMoa0810699 .
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献